326 related articles for article (PubMed ID: 19131563)
1. Bile Acid sulfation: a pathway of bile acid elimination and detoxification.
Alnouti Y
Toxicol Sci; 2009 Apr; 108(2):225-46. PubMed ID: 19131563
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC-MS/MS.
Huang J; Bathena SP; Csanaky IL; Alnouti Y
J Pharm Biomed Anal; 2011 Jul; 55(5):1111-9. PubMed ID: 21530128
[TBL] [Abstract][Full Text] [Related]
3. The profile of bile acids and their sulfate metabolites in human urine and serum.
Bathena SP; Mukherjee S; Olivera M; Alnouti Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of the 3-sulfates of N-acetylcysteine conjugated bile acids (BA-NACs) and their transient formation from BA-NACs and subsequent hydrolysis by a rat liver cytosolic fraction as shown by liquid chromatography/electrospray ionization-mass spectrometry.
Mitamura K; Sakai T; Nakai R; Wakamiya T; Iida T; Hofmann AF; Ikegawa S
Anal Bioanal Chem; 2011 Jun; 400(7):2061-72. PubMed ID: 21455648
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.
Chatterjee B; Echchgadda I; Song CS
Methods Enzymol; 2005; 400():165-91. PubMed ID: 16399349
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of mouse SULT2A8 reveals the mechanism of 7α-hydroxyl, bile acid sulfation.
Teramoto T; Nishio T; Kurogi K; Sakakibara Y; Kakuta Y
Biochem Biophys Res Commun; 2021 Jul; 562():15-20. PubMed ID: 34030040
[TBL] [Abstract][Full Text] [Related]
7. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
8. Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
Stiehl A; Earnest DL; Admirant WH
Gastroenterology; 1975 Mar; 68(3):534-44. PubMed ID: 1112455
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1).
Huang J; Bathena SP; Tong J; Roth M; Hagenbuch B; Alnouti Y
Xenobiotica; 2010 Mar; 40(3):184-94. PubMed ID: 20102295
[TBL] [Abstract][Full Text] [Related]
10. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
[TBL] [Abstract][Full Text] [Related]
11. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
[TBL] [Abstract][Full Text] [Related]
12. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients.
Hofmann AF; Loening-Baucke V; Lavine JE; Hagey LR; Steinbach JH; Packard CA; Griffin TL; Chatfield DA
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):598-606. PubMed ID: 18955863
[TBL] [Abstract][Full Text] [Related]
13. Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects.
Bathena SP; Thakare R; Gautam N; Mukherjee S; Olivera M; Meza J; Alnouti Y
Toxicol Sci; 2015 Feb; 143(2):296-307. PubMed ID: 25344562
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
Nie YF; Hu J; Yan XH
J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
[TBL] [Abstract][Full Text] [Related]
15. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
[TBL] [Abstract][Full Text] [Related]
16. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
[TBL] [Abstract][Full Text] [Related]
17. Difference in enzymatic sulfation of bile acids between the mouse and rat.
Takahashi A; Tanida N; Kang K; Umibe S; Kawaura A; Furukawa K; Hikasa Y; Satomi M; Shimoyama T
Tokushima J Exp Med; 1990 Jun; 37(1-2):1-8. PubMed ID: 2260084
[TBL] [Abstract][Full Text] [Related]
18. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
Zollner G; Marschall HU; Wagner M; Trauner M
Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
[TBL] [Abstract][Full Text] [Related]
19. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
[TBL] [Abstract][Full Text] [Related]
20. Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
Bathena SP; Thakare R; Gautam N; Mukherjee S; Olivera M; Meza J; Alnouti Y
Toxicol Sci; 2015 Feb; 143(2):308-18. PubMed ID: 25344563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
